Global Information
회사소개 | 문의 | 위시리스트

녹내장 치료제 리포트(2019년) : 세계 시장 분석(2018-2024년)

2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024

리서치사 Market Scope, LLC
발행일 2019년 06월 상품 코드 644810
페이지 정보 영문
가격
US $ 7,000 ₩ 8,166,000 PDF Only (Single User License)
US $ 10,500 ₩ 12,250,000 PDF & Excel (Enterprise License)


녹내장 치료제 리포트(2019년) : 세계 시장 분석(2018-2024년) 2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024
발행일 : 2019년 06월 페이지 정보 : 영문

세계의 녹내장 치료제(Glaucoma Pharmaceuticals) 시장은 2024년까지 연평균 성장률(CAGR)이 5.1%에 달할 것으로 전망됩니다.

세계의 녹내장 치료제 시장을 전망하고, 급성장이 전망되는 시장과 정체될 가능성이 높은 시장, 안과의를 보좌하는 존재인 검안의의 역할 확대, 개발도상국의 녹내장에 대한 새로운 관심 증가, 진단 비율을 높이는 최신 진단 기술 등에 대해 분석하여 전해드립니다.

조사 대상 지역(국가)

  • 미국
  • 서유럽
  • 일본
  • 기타 선진국
  • 중국
  • 인도
  • 라틴아메리카
  • 기타 지역

조사 토픽

  • 녹내장의 종류와 위험인자
  • 질병의 진단과 치료
  • 안과의와 검안의를 포함한 세계 녹내장 의료 제공자의 상황
  • 세계 환자 수의 현재 추산과 향후 5년간 예측
  • 현재 판매되고 있는 녹내장 치료제와 작용기서
  • 제네릭 의약품과 브랜드 의약품에 관한 논의와 시장에 대한 영향
  • 녹내장 치료제의 개발 파이프라인
  • 녹내장 치료제를 제조, 판매하고 있는 기업의 개요
KSA 19.06.19

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

What's New

In the 2019 Glaucoma Pharmaceuticals Market Report, now in its sixth edition, Market Scope forecasts that revenues in the global glaucoma pharmaceuticals market will grow with a CAGR of 5.1 percent to 2024. In the report, we examine growth in the fastest and slowest markets, the growing role of optometrists as ophthalmologist-extenders, new attention to glaucoma in developing countries, and new diagnostic technologies, which will increase the diagnostic rate.

Description

The 2019 Glaucoma Pharmaceuticals Report is Market Scope's comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and any other parties who may be interested in the global marketplace of glaucoma pharmaceuticals.

The 2019 Glaucoma Pharmaceuticals Market Report provides provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories, and we also use these categories in our global forecasts for disease prevalence. The report explores data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors.
  • Diagnosis and treatment of the disease.
  • A global view of glaucoma care providers, including ophthalmologists and optometrists.
  • Current estimates and five-year forecasts for disease prevalence worldwide.
  • Glaucoma medications in the marketplace and their mechanisms of action.
  • Discussion of generic versus branded drugs and their market impact.
  • The development pipeline for glaucoma pharmaceuticals.
  • Profiles of companies making and marketing glaucoma medications.

image1

Author Profile

Peter Downs

image1

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.


Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives,

Our report provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories (US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World), and we also use these categories in our global forecasts for disease prevalence. In addition, we explore data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors;
  • Diagnosis and treatment of the disease;
  • A global view of glaucoma care providers, including ophthalmologists and optometrists;
  • Current estimates and five-year forecasts for disease prevalence worldwide;
  • Glaucoma medications in the marketplace and their mechanisms of action;
  • Discussion of generic versus branded drugs and their market impact;
  • The development pipeline for glaucoma pharmaceuticals;
  • Profiles of companies making and marketing glaucoma medications.
Back to Top
전화 문의
F A Q